Clinical trial · Observational
Wearable Activity Tracking to Curb Hospitalizations
Wearable Activity Tracking to Curb Hospitalizations (WATCH)
NCT06587100CI-TRIAL-00122979WATCHrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematopoietic Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | CURATED_BROADER | 0.80 |
| Lymphatic System Neoplasm | — | UNRESOLVED | — |
| Malignant Solid Neoplasm | Malignant Solid Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Apple HealthKit-based devices | Device | — | UNRESOLVED |
| Fitbit | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Observational Group I: Fitbit only
- description
- Participants receive Fitbit device while undergoing non-interventional, standard of care, radiation therapy.
- interventionNames
- Device: Fitbit
- label
- Observational Group II: Fitbit + Apple HealthKit
- description
- Participants receive Fitbit device and will utilize personal Apple HealthKit-based devices (iPhone, Apple Watch, etc.) to concurrently contribute Apple HealthKit-based data while undergoing non-interventional, standard of care, radiation therapy.
- interventionNames
- Device: Fitbit
- Device: Apple HealthKit-based devices
Primary outcomes (4)
- measure
- Area under the receiver operating characteristic curve (AUC-ROC) of the step count model
- timeFrame
- Up to 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \>= 18. * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2 or Karnofsky Performance Scale (KPS) \>= 50%. * Able to understand study procedures and to comply with them for the entire length of the study. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. * Diagnosis of invasive malignancy. * Able to ambulate independently (without the assistance of a cane or walker). * Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement). * Not a previous participant on this protocol for subsequent courses. Exclusion Criteria: * Participants bound to a wheelchair. * Participants unable to ambulate independently (needing assistance of cane or walker).
References
Publications (0)
Data not yet available
No reference posted for this study.